
The rate of adverse events in patients using adalimumab remains low over time, with infections indicated as the most common adverse event, according to a study.

The rate of adverse events in patients using adalimumab remains low over time, with infections indicated as the most common adverse event, according to a study.

People who live with psoriasis have a higher risk of death from cardiovascular disease.

A new smartphone application from the American Academy of Dermatology provides evidence-based clinical guidelines for treating patients with psoriasis and psoriatic arthritis.